Rigel Pharmaceuticals (RIGL) Interest & Investment Income (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Interest & Investment Income of $1.2 million for Q1 2026, up 103.89% year-over-year from $591000.0 in Q1 2025, and down 3.06% quarter-over-quarter from $1.2 million in Q4 2025.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Interest & Investment Income (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 103.89% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.3 million (up 105.5% YoY), while the FY2025 annual figure was $3.7 million, up 75.96% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.2 million, down from $1.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was $1.2 million in Q4 2025, with the low at $21000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $552000.0 (2024), against an average of $584352.9.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income soared 2581.25% in 2022, then plunged 36.76% in 2024.
- Rigel Pharmaceuticals' Interest & Investment Income stood at $429000.0 in 2022, then jumped by 58.04% to $678000.0 in 2023, then slipped by 23.01% to $522000.0 in 2024, then jumped by 138.12% to $1.2 million in 2025, then slipped by 3.06% to $1.2 million in 2026.
- Business Quant data shows RIGL's Interest & Investment Income at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Rigel Pharmaceuticals | 902.02 Mn | 806.69 Mn | 70.18 Mn | 789,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 789,000.00 |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 753,000.00 |
| Mar 31, 2025 | 591,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 425,000.00 |
| Jun 30, 2024 | 552,000.00 |
| Mar 31, 2024 | 593,000.00 |
| Dec 31, 2023 | 678,000.00 |
| Sep 30, 2023 | 672,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 393,000.00 |
| Dec 31, 2022 | 429,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 14,000.00 |